306 related articles for article (PubMed ID: 3003590)
21. Noradrenaline release in the rat vena cava is inhibited by gamma-aminobutyric acid via GABAB receptors but not affected by histamine.
Schneider D; Schlicker E; Malinowska B; Molderings G
Br J Pharmacol; 1991 Oct; 104(2):478-82. PubMed ID: 1665738
[TBL] [Abstract][Full Text] [Related]
22. Regulation of cardiovascular sympathetic neurons by substance P and gamma-aminobutyric acid in the rat spinal cord.
Hasséssian H; Prat A; De Champlain J; Couture R
Eur J Pharmacol; 1991 Sep; 202(1):51-60. PubMed ID: 1723952
[TBL] [Abstract][Full Text] [Related]
23. Baclofen and noradrenergic function in the rat frontal cerebral cortex.
Losada ME
Eur J Pharmacol; 1991 May; 197(1):93-8. PubMed ID: 1909960
[TBL] [Abstract][Full Text] [Related]
24. gamma-Aminobutyric acid (GABA) receptor stimulation. IV. Effect of progabide (SL 76002) and other GABAergic agents on acetylcholine turnover in rat brain areas.
Scatton B; Bartholini G
J Pharmacol Exp Ther; 1982 Mar; 220(3):689-95. PubMed ID: 6278131
[No Abstract] [Full Text] [Related]
25. Interactions between GABAergic and serotoninergic systems with excitatory amino acid neurotransmission in the hypothalamic control of gonadotropin secretion in prepubertal female rats.
Scacchi P; Carbone S; Szwarcfarb B; Rondina D; Wuttke W; Moguilevsky JA
Brain Res Dev Brain Res; 1998 Jan; 105(1):51-8. PubMed ID: 9497079
[TBL] [Abstract][Full Text] [Related]
26. Regulation in the central norepinephrine neurotransmission induced in vivo by alpha adrenoceptor active drugs.
Braestrup C; Nielsen M
J Pharmacol Exp Ther; 1976 Sep; 198(3):596-608. PubMed ID: 185355
[TBL] [Abstract][Full Text] [Related]
27. The role of α₂ adrenoceptor in mediating noradrenaline action in the ventrolateral orbital cortex on allodynia following spared nerve injury.
Zhu JX; Xu FY; Xu WJ; Zhao Y; Qu CL; Tang JS; Barry DM; Du JQ; Huo FQ
Exp Neurol; 2013 Oct; 248():381-6. PubMed ID: 23872512
[TBL] [Abstract][Full Text] [Related]
28. Effects of gabaergic and serotoninergic systems on hypothalamic content of catecholamines during sexual development in female rats.
Rondina D; Ponzo OJ; Szwarcfarb B; Carbone S; Scacchi P; Moguilevsky JA
Neuro Endocrinol Lett; 2003; 24(1-2):46-9. PubMed ID: 12743531
[TBL] [Abstract][Full Text] [Related]
29. Effects of the GABA receptor agonist, progabide, upon local cerebral glucose utilization.
Cudennec A; Duverger D; Lloyd KG; MacKenzie ET; McCulloch J; Motohashi N; Nishikawa T; Scatton B
Brain Res; 1987 Oct; 423(1-2):162-72. PubMed ID: 2823984
[TBL] [Abstract][Full Text] [Related]
30. Opioid and prostaglandin mechanisms involved in the effects of GABAergic drugs on body temperature.
Sancibrian M; Serrano JS; Miñano FJ
Gen Pharmacol; 1991; 22(2):259-62. PubMed ID: 1647343
[TBL] [Abstract][Full Text] [Related]
31. GABAergic modulation of striatal cholinergic interneurons: an in vivo microdialysis study.
DeBoer P; Westerink BH
J Neurochem; 1994 Jan; 62(1):70-5. PubMed ID: 8263546
[TBL] [Abstract][Full Text] [Related]
32. Interaction between GABAergic neurotransmission and rat hypothalamic corticotropin-releasing hormone secretion in vitro.
Calogero AE; Gallucci WT; Chrousos GP; Gold PW
Brain Res; 1988 Oct; 463(1):28-36. PubMed ID: 3264201
[TBL] [Abstract][Full Text] [Related]
33. Role of GABA receptor subtypes in inhibition of primate spinothalamic tract neurons: difference between spinal and periaqueductal gray inhibition.
Lin Q; Peng YB; Willis WD
J Neurophysiol; 1996 Jan; 75(1):109-23. PubMed ID: 8822545
[TBL] [Abstract][Full Text] [Related]
34. The effects of the GABA-mimetic drugs, progabide and baclofen, on the biochemistry and function of 5-hydroxytryptamine and noradrenaline.
Gray JA; Metz A; Goodwin GM; Green AR
Neuropharmacology; 1986 Jul; 25(7):711-6. PubMed ID: 3018621
[TBL] [Abstract][Full Text] [Related]
35. gamma-Aminobutyric acid (GABA) receptor stimulation. III. Effect of progabide (SL 76002) on norepinephrine, dopamine and 5-hydroxytryptamine turnover in rat brain areas.
Scatton B; Zivkovic B; Dedek J; Lloyd KG; Constantinidis J; Tissot R; Bartholini G
J Pharmacol Exp Ther; 1982 Mar; 220(3):678-88. PubMed ID: 6278130
[No Abstract] [Full Text] [Related]
36. Different gamma-aminobutyric acid receptor subtypes are involved in the regulation of opiate-dependent and independent luteinizing hormone-releasing hormone secretion.
Masotto C; Wisniewski G; Negro-Vilar A
Endocrinology; 1989 Jul; 125(1):548-53. PubMed ID: 2544412
[TBL] [Abstract][Full Text] [Related]
37. Effects of GABAergic and noradrenergic injections into the cerebellar flocculus on vestibulo-ocular reflexes in the rabbit.
van Neerven J; Pompeiano O; Collewijn H
Prog Brain Res; 1991; 88():485-97. PubMed ID: 1667550
[TBL] [Abstract][Full Text] [Related]
38. The yohimbine-induced anticonflict effect in the rat, Part II. Neurochemical findings.
Söderpalm A; Ehrenström F; Söderpalm B
J Neural Transm Gen Sect; 1995; 100(3):191-206. PubMed ID: 8748666
[TBL] [Abstract][Full Text] [Related]
39. Modulation of the brain aversive system by GABAergic and serotonergic mechanisms.
Graeff FG; Brandão ML; Audi EA; Schütz MT
Behav Brain Res; 1986 Jul; 21(1):65-72. PubMed ID: 3017372
[TBL] [Abstract][Full Text] [Related]
40. GABAB receptor-mediated inhibition of GABAA receptor calcium elevations in developing hypothalamic neurons.
Obrietan K; van den Pol AN
J Neurophysiol; 1998 Mar; 79(3):1360-70. PubMed ID: 9497417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]